Article Information
History
- January 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Roy van der Meel1,2,3,*,
- Sam Chen2,4,
- Josh Zaifman4,5,
- Jayesh A. Kulkarni2,6,7,
- Xu Ran S. Zhang2,
- Ying K. Tam8,
- Marcel B. Bally9,10,11,12,
- Raymond M. Schiffelers1,
- Marco A. Ciufolini5,
- Pieter R. Cullis2,13 and
- Yuen Yi C. Tam2,4
- 1Laboratory of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
- 2Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada
- 3Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands
- 4Integrated Nanotherapeutics, Vancouver, BC, Canada
- 5Department of Chemistry, University of British Columbia, Vancouver, BC, Canada
- 6Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
- 7Evonik Vancouver Laboratories, Vancouver, BC, Canada
- 8Acuitas Therapeutics, Vancouver, BC, Canada
- 9Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, Canada
- 10Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
- 11Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
- 12Centre for Drug Research and Development, Vancouver, BC, Canada
- 13NanoMedicines Innovation Network, University of British Columbia, Vancouver, BC, Canada
- ↵*Corresponding author, Roy van der Meel (r.v.d.meel{at}tue.nl), Correspondence address: Department of Biomedical Engineering, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, Netherlands, The Netherlands